PCATALOG
British Caleva wet granulation torque rheometer was successfully installed in China Jiangzhong Pharmaceutical company
Pubdate：2020-09-29 Click：891
Jiangzhong Pharmaceutical company has always been committed to improving the quality and quality of common people's medicines. Its development strategy is positioned in the field of traditional Chinese medicine health care products and develops the health care functions of Chinese medicine. The wet mixing granulation torque rheometer can study the relationship between the powder and the binder using only 100 grams of sample, and the best binder ratio and mixing time can be obtained within an hour. British Caleva has developed multiple generations of extruders with different principles dedicated to the research of Chinese medicine, which will be conducive to the sustainable development of traditional Chinese medicine preparations.
Since its establishment more than 50 years ago, Caleva in the United Kingdom has designed and manufactured a variety of high-quality, sophisticated and cutting-edge products, and has a variety of patented equipment. It is the world's leader in laboratory and production equipment extruders and spheronizers. Models range from 10 grams of samples in the laboratory to dozens of tons in large-scale production. The granulation process of granular samples is completed. World-renowned pharmaceutical companies such as Pfizer and Roche use their equipment to develop products for users in the pharmaceutical and related industries. And production companies that provide equipment design, production and supply. Its main products include: wet granulation torque rheometer (MTR3), extruder and spheronizer, tablet and sphere coating machine, the company can also provide users with individually designed instruments and equipment.
Goodwill (Hong Kong) Technology Co., Ltd., as the agent of British Caleva in China, is fully responsible for the sales and after-sales service of all its products in China. Tel: 010-66155031/32/33 Website: www.goodwill-tech.com.
